Clinical trial
Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment
NCT00348439 · Bausch & Lomb Incorporated, Industry · Terminated
Key facts
| NCT number | NCT00348439 |
|---|---|
| Title | Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment |
| Official title | A Multicenter, Randomized, Double Masked, Placebo Controlled, Sequential Dose Response Study of Intravitreally Administered Plasmin for the Creation of a Posterior Vitreous Detachment (PVD) |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Vitreoretinal Traction Syndrome |
| Intervention type | Drug |
| Interventions | Plasmin, Vehicle |
| Enrollment | 29 |
| Start date | Apr 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jul 4, 2006 |
| Last update posted | Jun 21, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: